CAS: 13826-27-2; 2,2'-Bibenzo[d][1,3,2]Dioxaborole

相似化合物

274-07-7 55718-76-8 51901-85-0

上下游产品

儿萘酚硼烷 Benzo[1,3,2]Dioxaborole 274-07-7

B-氯-1,2-苯二酚硼烷置于sodium Amalgam体系中,用 甲苯 用作溶剂,以42%的收率获得双联邻苯二酚硼酸酯
参考文献:四烷氧基二硼烷(4)试剂的简短合成
标题:四烷氧基二硼烷(4)试剂的简短合成
摘要:一系列双(儿茶酚基)二硼烷(4)化合物b 2(1,2-O 2 C 6 H 4)2,B 2(1,2-O 2 C 6 H 3 Me-4)2的合成,B 2(1,2-O 2 C 6 H 2 Me 2-3,5)2,B 2 [1,2-O 2 C 6 H 3 Bu T-4)] 2和b 2 [1,2-O 2 C 6 H 2 Bu T2-3,5] 2,据报道.这些化合物是通过1%的钠/汞合金与相应的卤代胆硼烷反应而合成的,该卤代胆硼烷是从bcl 3或bbr 3与儿茶酚的反应中纯净形成的.在一个锅,B结合这两个步骤2 [1,2-O 2 C ^ 6 ħ 3卜吨-4)] 2,从制备的bcl 3和4-叔-Butylcatechol,和b 2 [1,2-O 2 C 6 H 2 Bu T 2-3,5] 2由3,5-二-叔丁基邻苯二酚和bbr 3(以克为单位).双(频哪醇)二硼烷(4)不是由氯频哪一种硼烷与na /
Doi:10.1021/om0208016

专利信息

专利号:EP-2647639-A1
优先权日:2012-04-06
标题:ß-boration of alkene and alkyne intermediates
权利人:LEK PHARMACEUTICALS
摘要:The present invention relates to the field of organic chemistry, and in particular to the preparation of β-borated compounds. These β-borated compounds can be used as intermediates in the synthesis of pharmaceutically active agents such as Sitagliptin.

专利号:US-11345665-B2
优先权日:2017-11-15
标题:Chiral 1,3-diarylimidazolium salt carbene precursor, synthesis method therefor, metal salt compound and application thereof
发明人：SHI SHILIANG; CAI YUAN; Yang Xintuo; LI FENG
权利人:SHANGHAI INST ORGANIC CHEMISTRY CAS
摘要:Chiral 1, 3-diarylimidazole salt carbene precursors, their methods of preparation, particularly transition metal complexes and their use in chemical synthesis are provided. In particular, an air and moisture stable chiral 1, 3-diarylimidazole carbene precursor Cu (I) complex has been prepared and applied to highly regio- and enantioselective Markovnikov hydroboration of unactivated terminal alkenes to form chiral boronic esters. Moreover, these new chiral NHCs can be potentially applied in various metal-catalyzed asymmetric transformations.

专利号:US-8697730-B2
优先权日:2007-10-26
标题 :5-lipoxygenase activating protein (FLAP) inhibitor
发明人：REWOLINSKI MELISSA VIRGINIA; SCHAAB KEVIN MURRAY; KING CHRISTOPHER DAVID; STOCK NICHOLAS SIMON
权利人:REWOLINSKI MELISSA VIRGINIA; SCHAAB KEVIN MURRAY; KING CHRISTOPHER DAVID; STOCK NICHOLAS SIMON; PANMIRA PHARMACEUTICALS LLC
摘要:Described herein are methods for the synthesis of 3-[5-(pyridin-2-ylmethoxy)-3-(2-methyl-2-propylthio)-1-[4-(2-methoxypyridin-5-yl)benzyl]-indol-2-yl]-2,2-dimethyl-propionic acid, pharmaceutically acceptable salts, pharmaceutically acceptable solvates thereof. Also described are pharmaceutical compositions suitable for oral administration to a mammal that include, as well as methods of using such oral pharmaceutical compositions for treating respiratory conditions or diseases, as well as other leukotriene-dependent or leukotriene mediated conditions or diseases.

专利号:US-12202782-B2
优先权日:2020-11-19
标 题:Processes and intermediates for preparing MCL1 inhibitors
发明人：DIXON DARRYL D; ISCHAY MICHAEL A; JOHNSON TREVOR C; MERIT JEFFREY E; REGENS CHRISTOPHER S; STANDLEY ERIC A; STEINHUEBEL DIETRICH P
权利人:GILEAD SCIENCES INC
摘要:The present disclosure relates to methods and intermediates for the synthesis of certain compounds that inhibit MCL1, for use in the treatment of cancers.

专利号:EP-4538282-A1
优先权日:2023-10-13
标 题 :Synthesis of emodepside

专利号:WO-2022101654-A1
优先权日:2020-11-13
标 题:Improved synthesis of crac channel inhibitors